Revenue: The sum of all revenue fields included for a company's operating activities.
Stoke Therapeutics, Inc. (STOK) had Revenue of $36.55M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$36.55M |
$-88.98M |
|
-- |
|
$36.55M |
|
$137.93M |
|
$-101.37M |
|
$12.39M |
|
$-88.98M |
|
$-88.98M |
|
$-88.98M |
|
$-88.98M |
|
$-88.98M |
|
$-88.98M |
|
$-101.37M |
|
$-100.84M |
|
54.01M |
|
54.01M |
|
$-1.65 |
|
$-1.65 |
|
| Balance Sheet Financials | |
$232.76M |
|
$3.91M |
|
$38.80M |
|
$271.56M |
|
$40.06M |
|
-- |
|
$2.48M |
|
$42.53M |
|
$229.02M |
|
$229.02M |
|
$229.02M |
|
54.03M |
|
| Cash Flow Statement Financials | |
$-86.85M |
|
$-107.47M |
|
$131.09M |
|
$192.01M |
|
$128.78M |
|
$-63.23M |
|
$27.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-277.31% |
|
-277.31% |
|
-275.85% |
|
-243.42% |
|
-243.42% |
|
$-87.05M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
-- |
|
52.22 |
|
6.99 |
|
-38.85% |
|
-38.85% |
|
-32.77% |
|
-38.85% |
|
$4.24 |
|
$-1.61 |
|
$-1.61 |
|